Top Markets
Coin of the day
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

VYGR
Pozycja w akcjach #18066
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating... Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Cena akcji
$3.54
Ostatnia synchronizacja: 2026-09-02
Kapitalizacja rynkowa
$213.59M
Zmiana (1 dzień)
3.06%
Zmiana (1 rok)
-3.94%
Kraj
US
Handel Voyager Therapeutics, Inc. (VYGR)

Kategoria

Historia ceny akcji dla Voyager Therapeutics, Inc. (VYGR)
Najwyższa cena zamknięcia: $3.48 dnia 2026-09-01

Najniższa cena zamknięcia: $21.80 dnia 2015-11-01
Historia cen akcji firmy Voyager Therapeutics, Inc. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -5.39%
2025 -31.67%
2024 -23.54%
2023 35.12%
2022 105.49%
2021 -64.56%
2020 -41.72%
2019 39.09%
2018 -32.12%
2017 8.56%
2016 -42.81%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.33 -8.75%
AU
$757.71 6.76%
CH